Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY -1.27%93 Net Current Asset Value is $3.26 as of Jun. 2026, which is 70% below its 10-year median of 10.72. GuruFocus rates PGNY with a GF Score™ of 93/100 and a GF Value™ of $28.77 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 9 Healthcare Plans companies, Progyny ranks better than 55.56% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Progyny's net current asset value per share for the quarter that ended in Jun. 2026 was $3.26.
The historical rank and industry rank for Progyny's Net Current Asset Value or its related term are showing as below:
PGNY'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.6 Med: 10.72 Max: 40.14
Current: 7.87
During the past 9 years, the highest Price-to-Net-Current-Asset-Value Ratio of Progyny was 40.14. The lowest was 4.60. And the median was 10.72.
PGNY's Price-to-Net-Current-Asset-Value is ranked better than 55.56% of 9
companies
in the Healthcare Plans industry
Industry Median: 9.34
vs PGNY: 7.87
Progyny (NAS:PGNY) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Progyny Net Current Asset Value Related Terms
Progyny Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Progyny's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PGNY vs CLOV, ALHC, PFHO: Net Current Asset Value Comparison
For the Healthcare Plans subindustry, Progyny's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny Price-to-Net-Current-Asset-Value vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Progyny's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $3.26 mean?
Progyny (PGNY) has a Net Current Asset Value of $3.26 as of Jun. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Progyny and its competitors. This is 70% below median its historical median of 10.72. Over the past decade, Progyny's Net Current Asset Value has ranged from 4.60 to 40.14. According to the industry distribution chart, Progyny ranks #4 out of 9 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Progyny's Net Current Asset Value too high?
Progyny's current Net Current Asset Value of $3.26 is 70% below median its 10-year median of 10.72. Over the past 10 years, this metric has ranged from a low of 4.60 to a high of 40.14. The Healthcare Plans industry median Net Current Asset Value is 9.34. Progyny's value of $3.26 is 65.1% below this industry median. Based on the distribution chart, Progyny ranks #4 out of 9 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Progyny has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Net Current Asset Value compare to CLOV and ALHC?
According to the Healthcare Plans industry distribution chart, Progyny ranks #4 out of 9 companies for Net Current Asset Value. This puts Progyny in the upper half of its industry. The industry median Net Current Asset Value is 9.34. Progyny's value of $3.26 is 65.1% below this benchmark. Historically, Progyny's own Net Current Asset Value has ranged from 4.60 to 40.14 over the past decade. While the company's 10-year median is 10.72 vs. the industry median of 9.34, Progyny has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Plans company?
The median Net Current Asset Value among Healthcare Plans companies is 9.34, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current Net Current Asset Value of $3.26 is 65.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median Net Current Asset Value is 9.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current Net Current Asset Value is $3.26, which is 70% below median its own 10-year median of 10.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.77, compared to a current price of $25.65 — trading 10.8% below its estimated fair value. The current Net Current Asset Value is $3.26, which is 70% below median its 10-year median of 10.72 and 65.1% below the Healthcare Plans industry median of 9.34. Progyny's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Progyny (PGNY), the current Net Current Asset Value is $3.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be undervalued.
The current stock price of $25.65 is trading 10.8% below its estimated GF Value™ of $28.77.
GuruFocus considers Progyny to be Modestly Undervalued.
Key valuation signals for PGNY:
Net Current Asset Value: $3.26 (70% below median its 10-year median of 10.72)
GF Value™: $28.77 vs. price of $25.65 (10.8% below fair value)
Industry Position: 65.1% below the Healthcare Plans median (#4 of 9)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
93GF Score
Get the complete analysis for PGNY
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
